저자의 연구 키워드

저자의 연구 키워드

#

#5-FU

#가격정책

#건강

#건강보험

#건강보험료 체납

#건강생활실천

#결핵 환자누락

#경제성 평가

#경증질환

#계열분화

#고령화

#공공 의약품 지출

#공공가치

#공공성

#공공제약사

#공정 무역

#과부담의료비

#국민건강보험

#근로

#노인

#노인의료비

#다항로짓모형

#대체효과

#만성질환

#문헌고찰

#미충족의료

#민간의료보험 보험료

#발생강도

#방문간호 서비스

#방법론적 고찰

#보건의료체계

#본인부담금

#부담능력

#북한

#불확실성

#비급여진료비

#비용 산출

#비용-효용분석

#사각지대

#사망 전 의료비

#사회자본

#생애의료비

#성과연동지불제

#시장점유율

#신약

#실재론적 평가

#약제비

#약품비

#연령

#외래

#요양급여비용

#위험선호도

#은퇴

#의료 빈곤화

#의료비

#의료비 부담

#의료비 지출

#의료이용

#의료이용 형평성

#의약품 접근

#의약품 제도

#이중차분법

#인구고령화

#인두제

#일차의료

#자료독점

#자료보호

#장기지속형 주사제

#재난적의료비

#재원조달

#재정적 보호

#저소득 가구

#저소득층

#정치적 통제

#제네릭 의약품

#제약산업

#조절효과분석

#조현병

#종단 자료

#종단분석

#주관적 건강상태

#주관적 기대수명

#중고령자

#지불제도

#지식재산권

#진료비 추계

#질병비용

#집중지수

#청구자료

#체계적 문헌고찰

#초기 프로그램 이론

#코로나19

#트럼프

#특허

#퍼스트제네릭

#필수 의약품

#한국-미국 자유무역협정

#한국복지패널

#한국의료패널

#항정신병 약물

#핵심 용어 : 미시모의실험모형

#핵심용어 : 미충족의료 해소

#핵심용어 : 재난적 의료비

#핵심용어 : 치매

#핵심용어 : 코로나19

#행위별 수가제

#허가특허 연계

#허가-특허 연계제도

#혁신성

#혁신적 의약품

#확장효과

#환태평양경제동반자협정

#ability-to-pay

#access to medicine

#Age

#Aging

#Anastrozole

#Antipsychotics

#AUSFTA

#Balloon effect

#Bioequivalence

#bosentan

#burden of health expenditure

#Capitation

#Cardiac rehabilitation

#Caregiver cost · Informal care · Costing method · Opportunity cost method · Proxy goods method · Contingent valuation method · Conjoint measurement

#case study

#Catastrophic health expenditure

#catastrophic impact

#Cesarean Section

#Child

#chronic diseases

#cisplatin

#Claims Data

#Coinsurance

#Competition

#Contribution evasion

#Contribution take-ups

#Copayment ceiling

#Cost

#Cost of illness

#cost sharing

#Cost-benefit analysis

#cost-effectiveness

#Costs and cost analysis

#cost-utility

#Cost-utility analysis.

#Covid-19

#Data exclusivity

#Death related cost

#Death-related costs

#dementia

#Depression

#Diagnostic test

#difference-in-difference analysis.

#docetaxel

#drug classes differentiation

#drug expenditures

#drug list price

#Drug substitution

#Drugs

#Drug-switch

#Economic evaluation

#Economic evaluation · Cost-effectiveness · Cost-utility · ICER threshold.

#Economic insecurity

#Elderly

#Elderly hospitalization

#Equity in Healthcare Utilization

#essential drugs

#expansion effect

#Fair Trade

#Fee-for-service plans

#financial protection

#First generic entry

#FTA

#generic

#Generic drugs

#Ginkgo biloba

#head and neck cancer

#health

#Health care costs

#Health care expenditure

#health equity

#health expenditure

#Health expenditures

#Health inequality

#Health insurance

#health spending

#Health status

#healthcare expenditure

#Healthcare Utilization

#health-promoting behaviors

#Heart failure

#HIwv Index

#Hospital

#Hospitals

#iloprost

#Impoverishing Health Spending

#incentive

#Income

#Industrial Accident Compensation Insurance

#Innovation

#innovative drugs

#institutional theory

#Insurance

#intellectual property

#isomorphism

#Key Words : Catastrophic Health Expenditure

#Key Words : Covid-19

#Key Words : Micro-simulation model

#Key Words : Visiting nursing

#Key words: unmet medical needs satisfaction

#Korea

#Korea Health Panel

#Korea Welfare Panel Study

#KORUSFTA

#Letrozole

#Literature review

#Location quotient

#Long-acting

#Longitudinal data

#Long-term care hospitals

#Low-income household

#Market share

#MCDA · Economic evaluation · Value matrix · Cost-effectiveness.

#medical care cost projection

#Mental health

#Meta-analysis

#methodological review

#Middle-aged men

#Mild cognitive impairment

#Minor illness

#moderating effect

#multi-level analysis

#Multinomial logit model

#Myocardial infarction

#National Health Insurance

#National Patients Sample data

#neoadjuvant chemotherapy

#new drugs

#Nursing staff

#older adults

#organization

#out-of-pocket

#Out-of-pocket payments

#Outpatient care utilization

#paclitaxel

#Paliperidone palmitate

#Panel study

#Parents

#patent

#Patent linkage

#Payment system

#Pensions

#Pharmaceutical Affairs

#pharmaceutical company

#Pharmaceutical expenditure

#Pharmaceutical Industry

#Pharmaceutical prices

#Pharmaceuticals

#pharmacoeconomics

#Physician behavior

#Policy evaluation

#Political Control

#Population ageing

#Positive list

#poverty impact

#Price policy

#Primary health care

#private health insurance premium

#Public Pharmaceutical Expenditure

#Public policy

#Public Value

#Publicness

#pulmonary arterial hypertension

#Reimbursement

#Reimbursement restriction

#resource dependent theory

#retirement

#risk preference

#Risk sharing arrangements · Drug pricing · Drug reimbursement.

#Schizophrenia

#Seoul

#Social class

#Socioeconomic position

#South Korea

#State-Owned Pharmaceutical Enterprise

#subjective health status

#subjective life expectancy

#substitution effect

#Suicidal ideation

#Systematic review

#The elderly

#the poor

#the social capital

#Therapeutic equivalency

#Time series

#Trans-Pacific Partnership Agreements

#Trump

#Uncertainty

#uncovered medical services

#unmet medical need

#vulnerable population

#Wealth

#work